SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Transformative impact of positive psychotherapy‐based hope placement program on life goals and hope level of individuals with multiple sclerosis
PUBLIC HEALTH NURSING
, cilt.0, sa.0, ss.1-16, 2024 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 6
- Mentions
- News Mentions: 1
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.83, 2024 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 6
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
JOURNAL OF MEDICAL ECONOMICS
, cilt.27, sa.1, ss.109-125, 2024 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 7
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.94, ss.1004-1011, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 15
- Mentions
- News Mentions: 1
Risk of secondary progressive multiple sclerosis after early worsening of disability
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.94, sa.12, ss.984-991, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 5
- Captures
- Readers: 7
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.79, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 6
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
BRAIN
, cilt.146, sa.11, ss.4633-4644, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 24
- Mentions
- Blog Mentions: 1
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients with Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
JAMA Neurology
, cilt.80, sa.10, ss.1080-1088, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 28
- Captures
- Readers: 55
- Mentions
- News Mentions: 5
- Social Media
- Shares, Likes & Comments: 8
Dietary Inflammatory Index score and its association with body mass index, body fat percentage, body fat mass, and lipid profile in patients with multiple sclerosis
Turkish Journal of Medical Sciences
, cilt.53, sa.5, ss.1155-1165, 2023 (SCI-Expanded)
PlumX Metrics
- Usage
- Downloads: 378
- Abstract Views: 166
- Captures
- Readers: 5
Newly Diagnosed Tumefactive Demyelinating Lesion and Multiple Sclerosis After COVID-19 Infection
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.60, sa.3, ss.223-230, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 8
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting
Multiple Sclerosis and Related Disorders
, cilt.77, 2023 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 6
Disability accrual in primary and secondary progressive multiple sclerosis
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.94, sa.9, ss.707-717, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 5
- Captures
- Readers: 19
- Mentions
- News Mentions: 1
- Social Media
- Shares, Likes & Comments: 45
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
JAMA NEUROLOGY
, cilt.80, sa.8, ss.789-797, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 14
- Captures
- Readers: 56
- Mentions
- News Mentions: 38
- Social Media
- Shares, Likes & Comments: 2
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study
Multiple Sclerosis Journal
, cilt.29, sa.9, ss.1099-1106, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 4
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation
JAMA Neurology
, cilt.80, sa.7, ss.739-748, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 14
- Captures
- Readers: 28
- Mentions
- Blog Mentions: 1
- News Mentions: 8
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
Multiple Sclerosis and Related Disorders
, cilt.75, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 6
- Captures
- Readers: 16
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
NEUROLOGICAL SCIENCES
, cilt.44, ss.2121-2129, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 14
- Mentions
- News Mentions: 1
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
EUROPEAN JOURNAL OF NEUROLOGY
, cilt.30, sa.4, ss.1014-1024, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 19
- Mentions
- News Mentions: 2
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, sa.2211-0348, ss.1-4, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 3
- Captures
- Readers: 10
- Social Media
- Shares, Likes & Comments: 48
Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity?
NUTRITIONAL NEUROSCIENCE
, cilt.26, sa.3, ss.228-234, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 24
- Captures
- Readers: 27
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment
Noropsikiyatri Arsivi
, cilt.60, sa.1, ss.23-27, 2023 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 3
Comparative effectiveness in multiple sclerosis: A methodological comparison
Multiple Sclerosis Journal
, cilt.29, sa.3, ss.326-332, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 3
- Policy Citations: 3
- Captures
- Readers: 8
- Mentions
- News Mentions: 1
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity
Multiple Sclerosis and Related Disorders
, cilt.70, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 7
- Mentions
- News Mentions: 1
External validation of a clinical prediction model in multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL
, cilt.29, sa.2, ss.261-269, 2023 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 3
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Multiple Sclerosis Journal
, cilt.29, sa.2, ss.221-235, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 16
- Captures
- Readers: 32
- Mentions
- News Mentions: 1
The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVID-19 in Multiple Sclerosis
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.60, sa.3, ss.252-256, 2023 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 8
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.94, sa.1, ss.23-30, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 11
- Policy Citations: 1
- Captures
- Readers: 16
- Mentions
- Blog Mentions: 1
- Social Media
- Shares, Likes & Comments: 3
Reliability and validity of the Turkish version of speech pathology-specific questionnaire for persons with multiple sclerosis (SMS-TR)
INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY
, cilt.25, sa.6, ss.841-848, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 8
- Social Media
- Shares, Likes & Comments: 73
Relationship between stigma and symptom burden in patients with multiple sclerosis
Neurology Asia
, cilt.28, sa.2, ss.359-366, 2023 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 10
Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.224, 2023 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 24
- Mentions
- News Mentions: 1
Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.323-332, 2023 (SCI-Expanded)
PlumX Metrics
- Usage
- Downloads: 516
- Abstract Views: 233
- Captures
- Readers: 8
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
BMC Medical Research Methodology
, cilt.22, sa.1, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 15
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Neurology
, cilt.99, sa.17, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 18
- Captures
- Readers: 32
- Mentions
- Blog Mentions: 1
- News Mentions: 2
Stereological and comparative evaluation of the carpal tunnel in patients with carpal tunnel syndrome using magnetic resonance images
JOURNAL OF THE ANATOMICAL SOCIETY OF INDIA
, cilt.71, sa.4, ss.272-278, 2022 (SCI-Expanded)
PlumX Metrics
- Mentions
- News Mentions: 1
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
Multiple Sclerosis Journal
, cilt.28, sa.11, ss.1752-1761, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 3
- Policy Citations: 2
- Captures
- Readers: 8
- Mentions
- News Mentions: 1
The effect of a psychoeducation program based on the rational emotional behavioral approach in individuals with multiple sclerosis diagnosis: A randomized controlled trial
PERSPECTIVES IN PSYCHIATRIC CARE
, cilt.58, sa.4, ss.1449-1459, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 21
- Social Media
- Shares, Likes & Comments: 43
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.93, sa.12, ss.1322-1329, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 9
- Mentions
- News Mentions: 1
Confirmed disability progression as a marker of permanent disability in multiple sclerosis
European Journal of Neurology
, cilt.29, sa.8, ss.2321-2334, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 22
- Captures
- Readers: 21
- Mentions
- News Mentions: 3
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis An International Registry Study
NEUROLOGY
, cilt.98, sa.24, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 20
- Captures
- Readers: 27
- Mentions
- News Mentions: 2
Effect of self-acupressure on fatigue in patients with multiple sclerosis
COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE
, cilt.47, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 6
- Captures
- Readers: 40
- Mentions
- News Mentions: 1
- Social Media
- Shares, Likes & Comments: 10
10.1016/j.cmpb.2021.106479
Computer Methods and Programs in Biomedicine
, ss.1-3, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 7
Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
PharmacoEconomics
, cilt.40, sa.3, ss.323-339, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 6
- Captures
- Readers: 32
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.58, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 6
- Captures
- Readers: 17
- Social Media
- Shares, Likes & Comments: 7
Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression A coexistência da síndrome das pernas inquietas e esclerose múltipla agrava ansiedade e depressão
Arquivos de Neuro-Psiquiatria
, cilt.80, sa.2, ss.168-172, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 16
- Captures
- Readers: 13
A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.57, 2022 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 12
- Captures
- Readers: 44
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
Muscle and Nerve
, cilt.64, sa.6, ss.662-669, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 10
- Policy Citations: 1
- Captures
- Readers: 35
- Social Media
- Shares, Likes & Comments: 47
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
CNS Drugs
, cilt.35, sa.11, ss.1217-1232, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 9
- Captures
- Readers: 28
Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
JOURNAL OF THE NEUROLOGICAL SCIENCES
, cilt.430, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 12
- Captures
- Readers: 20
Tofacitinib enhances remyelination and improves myelin integrity in cuprizone-induced mice
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
, cilt.43, sa.6, ss.790-798, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 9
- Captures
- Readers: 17
Determinants of therapeutic lag in multiple sclerosis
Multiple Sclerosis Journal
, cilt.27, sa.12, ss.1838-1851, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 3
- Policy Citations: 3
- Captures
- Readers: 27
- Mentions
- Blog Mentions: 1
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018
CNS Drugs
, cilt.35, sa.10, ss.1097-1106, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 8
- Captures
- Readers: 24
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Computer Methods and Programs in Biomedicine
, cilt.208, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 27
- Captures
- Readers: 70
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies
Multiple Sclerosis and Related Disorders
, cilt.53, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 10
- Captures
- Readers: 34
- Mentions
- Blog Mentions: 1
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey
International Journal of Clinical Practice
, cilt.75, sa.7, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 13
- Mentions
- News Mentions: 1
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.52, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 23
- Captures
- Readers: 60
- Social Media
- Shares, Likes & Comments: 13
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology
, cilt.96, sa.24, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 42
- Policy Citations: 2
- Captures
- Readers: 61
- Mentions
- News Mentions: 3
- Social Media
- Shares, Likes & Comments: 1
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD
Annals of Neurology
, cilt.89, sa.6, ss.1088-1098, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 38
- Policy Citations: 1
- Captures
- Readers: 76
- Social Media
- Shares, Likes & Comments: 31
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis
Multiple Sclerosis Journal
, cilt.27, sa.5, ss.755-766, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 12
- Policy Citations: 1
- Captures
- Readers: 40
- Mentions
- News Mentions: 1
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
Neurology
, cilt.96, sa.5, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 56
- Captures
- Readers: 98
- Mentions
- News Mentions: 1
- Social Media
- Shares, Likes & Comments: 41
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Neurology
, cilt.96, sa.4, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 45
- Captures
- Readers: 79
- Mentions
- News Mentions: 1
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
NEUROLOGY
, cilt.96, sa.2, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 6
- Captures
- Readers: 38
- Mentions
- Blog Mentions: 1
Benefits of eculizumab in AQP4+neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.47, 2021 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 28
- Captures
- Readers: 61
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology
, cilt.19, sa.12, ss.988-997, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 59
- Captures
- Readers: 149
- Mentions
- Blog Mentions: 2
- News Mentions: 6
- References: 1
- Social Media
- Shares, Likes & Comments: 30
Association of Sustained Immunotherapy with Disability Outcomes in Patients with Active Secondary Progressive Multiple Sclerosis
JAMA Neurology
, cilt.77, sa.11, ss.1398-1407, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 24
- Captures
- Readers: 66
- Mentions
- News Mentions: 4
Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.197, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 17
- Captures
- Readers: 35
Screening of dysphagia by DYMUS (Dysphagia in multiple sclerosis) and SWALQoL (Swallowing quality of life) surveys in patients with multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.45, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 5
- Captures
- Readers: 43
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Brain
, cilt.143, sa.9, ss.2742-2756, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 27
- Policy Citations: 1
- Captures
- Readers: 87
Ofatumumab versus Teriflunomide in Multiple Sclerosis
The new england journal o f medicine
, ss.546-557, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 403
- Patent Family Citations: 1
- Policy Citations: 7
- Usage
- Downloads: 160
- Abstract Views: 30
- Captures
- Readers: 549
- Mentions
- Blog Mentions: 6
- News Mentions: 243
- References: 4
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
Annals of Clinical and Translational Neurology
, cilt.7, sa.8, ss.1327-1339, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 11
- Policy Citations: 1
- Captures
- Readers: 47
- Social Media
- Shares, Likes & Comments: 30
The Effectiveness of New Adiposity Indices on Plasma Lipid Profile in Patients with Multiple Sclerosis: A Cross-Sectional Study with A Body Shape Index, Body Roundness Index, and Visceral Adiposity Index
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.43, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 5
- Captures
- Readers: 25
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab
Journal of Neurology
, cilt.267, sa.7, ss.1991-2001, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 28
- Policy Citations: 1
- Captures
- Readers: 88
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.42, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 7
- Captures
- Readers: 19
Early clinical markers of aggressive multiple sclerosis
Brain
, cilt.143, sa.5, ss.1400-1413, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 37
- Captures
- Readers: 92
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder
Multiple Sclerosis and Related Disorders
, cilt.38, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 37
- Captures
- Readers: 84
A Multicenter International Study to Evaluate Different Aspects of Relationship Between MS and Pregnancy
Multiple Sclerosis and Related Disorders
, ss.1-2, 2020 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 2
Risk of secondary progressive multiple sclerosis: A longitudinal study
MULTIPLE SCLEROSIS JOURNAL
, cilt.26, sa.1, ss.79-90, 2020 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 56
- Policy Citations: 1
- Captures
- Readers: 156
- Mentions
- Blog Mentions: 1
- News Mentions: 1
Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.56, sa.4, ss.269-272, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 17
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients FINE Trial
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.56, sa.4, ss.253-257, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 2
- Captures
- Readers: 27
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.36, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 5
- Captures
- Readers: 49
Eculizumab improves fatigue in refractory generalized myasthenia gravis
Quality of Life Research
, cilt.28, sa.8, ss.2247-2254, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 23
- Captures
- Readers: 120
- Social Media
- Shares, Likes & Comments: 7
Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases
Multiple Sclerosis and Related Disorders
, cilt.33, ss.94-99, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 18
- Captures
- Readers: 37
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.381, sa.7, ss.614-625, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 565
- Policy Citations: 13
- Captures
- Readers: 532
- Mentions
- News Mentions: 30
- Social Media
- Shares, Likes & Comments: 218
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Muscle and Nerve
, cilt.60, sa.1, ss.14-24, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 93
- Patent Family Citations: 1
- Policy Citations: 4
- Usage
- Abstract Views: 7
- Captures
- Readers: 242
- Mentions
- News Mentions: 18
- Social Media
- Shares, Likes & Comments: 2
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.90, sa.4, ss.458-468, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 68
- Captures
- Readers: 173
- Social Media
- Shares, Likes & Comments: 15
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Multiple Sclerosis and Related Disorders
, cilt.28, ss.235-243, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 37
- Captures
- Readers: 101
- Mentions
- News Mentions: 1
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
, cilt.321, sa.2, ss.175-187, 2019 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 364
- Policy Citations: 6
- Captures
- Readers: 505
- Mentions
- Blog Mentions: 4
- News Mentions: 12
- Social Media
- Shares, Likes & Comments: 202
Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis
JAMA Neurology
, cilt.75, sa.11, ss.1407-1415, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Policy Citations: 1
- Citation Indexes: 23
- Captures
- Readers: 67
- Social Media
- Shares, Likes & Comments: 115
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis
Multiple Sclerosis Journal
, cilt.24, sa.12, ss.1617-1626, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 38
- Captures
- Readers: 100
- Mentions
- Blog Mentions: 1
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
the new england journal of medicine
, ss.1017-1027, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 234
- Policy Citations: 6
- Captures
- Readers: 295
- Mentions
- Blog Mentions: 2
- News Mentions: 14
- References: 4
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Journal of the Neurological Sciences
, cilt.391, ss.72-76, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 24
- Captures
- Readers: 89
Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL
, cilt.24, sa.9, ss.1205-1211, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 26
- Captures
- Readers: 62
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.22, ss.70-76, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 23
- Captures
- Readers: 82
Reply to: Comment on Y.D. Fragoso et al.: “Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod” [Mult. Scler. Relat. Disord. (2017)]
Multiple Sclerosis and Related Disorders
, cilt.22, ss.166, 2018 (SCI-Expanded)
PlumX Metrics
- Captures
- Readers: 12
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
MULTIPLE SCLEROSIS JOURNAL
, cilt.24, sa.5, ss.642-652, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 38
- Policy Citations: 1
- Captures
- Readers: 68
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
The Lancet
, cilt.391, sa.10127, ss.1263-1273, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 145
- Policy Citations: 1
- Clinical Citations: 1
- Captures
- Readers: 976
- Mentions
- Blog Mentions: 7
- News Mentions: 128
- Social Media
- Shares, Likes & Comments: 28
The use of non-steroidal anti-inflammatory drugs diseases
JOURNAL OF CHEMICAL NEUROANATOMY
, cilt.87, ss.12-24, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 24
- Captures
- Readers: 57
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Multiple Sclerosis and Related Disorders
, cilt.19, ss.105-108, 2018 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 20
- Captures
- Readers: 55
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
LANCET NEUROLOGY
, sa.12, ss.976-986, 2017 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 388
- Patent Family Citations: 5
- Policy Citations: 10
- Captures
- Readers: 508
- Mentions
- News Mentions: 5
- References: 1
- Social Media
- Shares, Likes & Comments: 35
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
BRAIN
, cilt.140, ss.2426-2443, 2017 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 99
- Captures
- Readers: 222
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice
MULTIPLE SCLEROSIS JOURNAL
, cilt.23, sa.10, ss.1346-1357, 2017 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 17
- Policy Citations: 1
- Captures
- Readers: 55
- Mentions
- News Mentions: 1
Prognostic indicators in pediatric clinically isolated syndrome
Annals of Neurology
, cilt.81, sa.5, ss.729-739, 2017 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 37
- Captures
- Readers: 100
- Mentions
- News Mentions: 1
Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.54, sa.1, ss.11-14, 2017 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 16
- Captures
- Readers: 45
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
The new england journal o f medicine
, sa.3, ss.221-234, 2017 (SCI-Expanded)
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.87, sa.12, ss.1343-1349, 2016 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 62
- Policy Citations: 2
- Captures
- Readers: 157
- Mentions
- Blog Mentions: 2
- News Mentions: 2
- Social Media
- Shares, Likes & Comments: 20
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL
, cilt.22, sa.4, ss.520-532, 2016 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 35
- Captures
- Readers: 93
- Mentions
- Blog Mentions: 1
- Social Media
- Shares, Likes & Comments: 14
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
the lancet
, ss.1075-1084, 2016 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 352
- Policy Citations: 9
- Captures
- Readers: 512
- Mentions
- Blog Mentions: 3
- News Mentions: 2
- References: 2
Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis
ANNALS OF NEUROLOGY
, cilt.77, sa.3, ss.425-435, 2015 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 144
- Policy Citations: 4
- Captures
- Readers: 180
- Mentions
- Blog Mentions: 2
- Social Media
- Shares, Likes & Comments: 3
Lack of association of the CD14/C-159T polymorphism with susceptibility and progression parameters in Turkish multiple sclerosis patients
JOURNAL OF NEUROIMMUNOLOGY
, cilt.250, sa.1-2, ss.83-86, 2012 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 19
Prolonged cerebellar ataxia associated with lithium-valproic acid intoxication
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, cilt.13, sa.2, ss.166, 2012 (SCI-Expanded)
Pure Sensory Stroke Due to Bilateral Basal Ganglion Hemorrhage: A Case Report
TURKISH NEUROSURGERY
, cilt.20, sa.3, ss.406-408, 2010 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 10
- Captures
- Readers: 12
Hypothyroid myopathy with manifestations of Hoffman's syndrome and myasthenia gravis
THYROID
, cilt.18, sa.2, ss.259-262, 2008 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 10
- Captures
- Readers: 14
- Mentions
- References: 1
Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis
ACTA NEUROLOGICA SCANDINAVICA
, cilt.115, sa.5, ss.325-330, 2007 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 43
- Clinical Citations: 1
- Captures
- Readers: 34
- Social Media
- Shares, Likes & Comments: 600
Frontal functions in young patients with essential tremor: A case comparison study
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
, cilt.18, sa.1, ss.64-72, 2006 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 21
- Captures
- Readers: 26
Congenital afibrinogenemia complicated by spontaneous cerebral hemorrhage and unusually quick resorption
JOURNAL OF NEUROLOGY
, cilt.252, sa.3, ss.367-368, 2005 (SCI-Expanded)
PlumX Metrics
- Citations
- Citation Indexes: 4
- Captures
- Readers: 2
Diğer Dergilerde Yayınlanan Makaleler
Vision Transformer Based Classification of Neurological Disorders from Human Speech
Firat University journal of experimental and computational engineering (Online)
, cilt.3, sa.2, ss.160-174, 2024 (Hakemli Dergi)
Multipl Skleroz Tanılı Bireylerin Öznel İyi Oluş Düzeyleri Subjective Well-Being Levels of Individuals Diagnosed with Multiple Sclerosis
Türkiye Klinikleri Hemşirelik Bilimleri Dergisi
, cilt.14, sa.3, ss.861-867, 2022 (Hakemli Dergi)
PlumX Metrics
- Captures
- Readers: 1
EVALUATION OF EATING ATTITUDES IN PATIENTS ATTENDING MULTIPLE SCLEROSIS PATIENT CAMP
Samsun Sağlık Bilimleri Dergisi
, cilt.6, sa.1, ss.49-54, 2021 (Hakemli Dergi)
PlumX Metrics
- Citations
- Citation Indexes: 1
- Captures
- Readers: 1
Üniversite öğrencilerinde sigara kullanımı ve nikotin bağımlılık düzeylerinin belirlenmesi
The Turkish Journal On Addıctıons
, cilt.6, sa.4, ss.168-181, 2020 (Hakemli Dergi)
Değiştirilemez Gerçekte Anlam Bulmak: Varoluşcu Logoterapinin MS Tanılı Bireylerde Depresyon, Anksiyete, Affektif Kişilik Ve Yaşam Kalitesi Düzeylerine Etkisi
Samsun Sağlık Bilimleri Dergisi
, cilt.5, sa.2, ss.182-190, 2020 (Hakemli Dergi)
MULTİPL SKLEROZ HASTALARINA VE AİLELERİNE VERİLEN BESLENME EĞİTİMİNİN BİLGİ DÜZEYİ VE BESLENME ALIŞKANLIKLARINA ETKİSİNİN DEĞERLENDİRİLMESİ
Samsun Sağlık Bilimleri Dergisi
, cilt.4, sa.2, ss.77-85, 2019 (Hakemli Dergi)
The Benefits of Visual Evoked Potential Examination in the Diagnosis and Prognosis Of Multiple Sclerosis
Akonder Journal of Advanced Neurological Science
, cilt.3, sa.4, ss.167-171, 2015 (Hakemli Dergi)
The Effects of Structural Transformations in Economy on Labor Markets The Case of OECD Countries
International Journal of Business and Social Science
, cilt.5, sa.9, ss.230-237, 2014 (Hakemli Dergi)
Anti-John Cunningham Virus antibody prevalence in multiple sclerosis patients in Turkey
JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE
, cilt.31, sa.1, ss.31-36, 2014 (Scopus)
Santral Sinir Sistemi Tutulumu ile Prezente Olan Sjögren Sendromu
Journal of Clinical and Analytical Medicine
, cilt.3, sa.1, ss.94-96, 2012 (Hakemli Dergi)
Lityum-valproik asit zehirlenmesi sonrasında ortaya çıkan uzun süreli serebellar ataksi
Anadolu Psikiyatri Dergisi
, cilt.2, sa.13, ss.166, 2012 (Hakemli Dergi)
Multipl sklerozda kaplan gözü işareti: Bir olgu sunumu
Parkinson hastalığı ve Hareket Bozuklukları Dergisi
, cilt.1, sa.14, ss.17-20, 2011 (Hakemli Dergi)
Sexual dysfunction in multiple sclerosis patients.
Journal of Experimental and Clinical Medicine
, cilt.26, sa.2, ss.81-85, 2009 (Hakemli Dergi)
’’Üç Subakut Kombine Dejenerasyon Olgusunun Spinal MRG ve Klinik Bulguları’’
TÜRKİYE KLİNİKLERİ NÖROLOJİ
, cilt.4, ss.41-46, 2009 (Hakemli Dergi)
Santral Sinir Sistemi Tutulumu Olan ve Bilateral Oftalmopleji Kliniği ile Prezente Olan Mukormikoz Olgusu Olgu Sunumu
Türk Nöroloji Dergisi
, cilt.15, sa.2, ss.89-93, 2009 (Hakemli Dergi)
Parkinsonizmle Ortaya Çıkan Kronik Karaciğer Sirozu İki Olgu Sunumu
Parkinson Hastalığı ve Hareket Bozuklukları Dergisi
, cilt.12, sa.1, ss.25-29, 2009 (Hakemli Dergi)
Statinlerin Nöroloji Pratiğindeki Yeri
Deneysel ve Klinik Tıp Dergisi
, cilt.26, sa.2, ss.55-61, 2009 (Scopus)
’’Guillain-Barre Sendromunda klinik ve demografik özellikler’’
Fırat Tıp Dergisi
, cilt.12, ss.112-114, 2007 (Hakemli Dergi)
Talamus un Anatomik ve Fonksiyonel Önemi
Ondokuz Mayıs Üniversitesi Tıp Dergisi
, cilt.27, sa.4, ss.144-154, 2007 (Hakemli Dergi)
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
MULTİPL SKLEROZ TEDAVİSİNDE DİMETİL FUMARATIN İKİ YILLIK TÜRKİYE GERÇEK YAŞAM VERİSİ
59.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 Aralık 2023
PARANEOPLAZİ PANELİ POZİTİF 110 HASTANIN DEMOGRAFİK ÖZELLİKLERİ
58.Ulusal Nöroloji Kongresi, Muğla, Türkiye, 19 Kasım 2022
MİYELİN OLİGODENDROSİT GLİKOPROTEİN ANTİKORU İLE İLİŞKİLİ HASTALIK TEDAVİSİNDE RİTUKSİMAB ETKİNLİĞİ: ÇOK MERKEZLİ, RETROSPEKTİF ULUSAL ÇALIŞMA
58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 19 - 24 Kasım 2022
MULTİPL SKLEROZDA İMMÜNOMODÜLATÖR TEDAVİ ALAN VE ALMAYAN HASTALARDA İNAKTİVE VİRÜS VE MRNA AŞILARINI TAKİBEN HÜMORAL YANITLAR VE HÜCRESEL İMMÜN PROFİLLER
58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 19 - 24 Kasım 2022
GEBELİĞİN NÖROMYELİTİS OPTİKA SPEKTRUM HASTALIĞI (NMOSD) VE MYELİN OLİGODENDROSİT GLİKOPROTEİN İLİŞKİLİ HASTALIK (MOGAD) PROGNOZU ÜZERİNE ETKİ
58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 19 - 24 Kasım 2022
SS-89 MİYELİN OLİGODENDROSİT GLİKOPROTEİN ANTİKORU İLE İLİŞKİLİ HASTALIK TEDAVİSİNDE RİTUKSİMAB ETKİNLİĞİ: ÇOK MERKEZLİ, RETROSPEKTİF ULUSAL ÇALIŞMA
58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 18 Kasım 2022
EPİLEPSİ HASTALARINDA UYKU BOZUKLUKLARININ YAŞAM KALİTESİNE ETKİSİ; TÜRKİYE’DEN ÇOK MERKEZLİ ÇALIŞMA
58. ULUSAL NÖROLOJİ KONGRESİ, 19 Ekim 2022
Multiple Skleroz Hastalarında Geniş Band Timpanometri Bulguları
9. Ulusal Otoloji Nörootoloji Kongresi-11. Koklear İmplant ve Odyoloji Kongresi, Türkiye, 10 Mart 2022
Obez Olan ve Olmayan Multipl Skleroz Hastalarında Kontrolateral Supresyon Bulguları
11.Ulusal Obezite Kongresi, İzmir, Türkiye, 3 - 06 Mart 2022
Biopsychosocial Evaluation in A Case with Multipl Sclerosis Accompanied by Lower Urinary Tract Dysfunctions
3rd World Congress on Primary Healthcare and Medicare Summit, 2022, Samsun, Türkiye, 07 Şubat 2022
Multipl Skleroz Klinik Takip ve İzleminde Akıllı Telefon Uygulaması(MUTLUSUN)
57.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021
Multipl Skleroz Hastalarının Alternatif Ürün Kullanım Oranlarının Saptanması ve Hastalık Seyri üzerine Olan Etkisinin Değerlendirilmesi
57.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021
Multipl Skleroz ve Mikrobiyota
8. Ulusal Bağırsak Mikrobiyotası ve Probiyotik Kongresi, Antalya, Türkiye, 11 - 14 Eylül 2021
Artificial Intelligence Based Gait Analysis in Multiple Sclerosis Patients
1st International Balkan Congress on Neurology and Neuroscience, Türkiye, 3 - 04 Eylül 2021
Tıpta dijitalleşme ve yapay zeka
Azerbeycan Tıpta Güncel Sorunlar Kongresi, Azerbaycan, 08 Ekim 2021
Sinir Bilim ve Yapay Zeka
6. İlaç ve Tedavi Kongresi-Akıllı İlaç Kullanımı, Türkiye, 22 - 26 Eylül 2021
Sanal Nörorehabilitasyon Uygulamasının Multipl Skleroz Hastalarının Yaşam Kalitesine ve Hastalık Seyrine Etkisi
Eskişehir Nöroloji Günleri Nöro-Romatoloji Sempozyumu Multipl Skleroz ve Ayrıcı Tanıda Romatolojik Hastalıklar, Türkiye, 3 - 05 Eylül 2021
Multıple Skleroz Hastalarında Kontralateral Supresyon
8. Ulusal Otoloji Nörotoloji Kongresi, online, Türkiye, 26 Haziran 2021
AİLE KATILIMLI BESLENME EĞİTİMİNİN MULTİPL SKLEROZ HASTALARININ BİLGİ DÜZEYİ VE BESLENMEYE YÖNELİK DAVRANIŞLARINA ETKİSİ
4th International Health Sciences and Life Congress, Burdur, Türkiye, 8 - 10 Nisan 2021
Multipl Skleroz (MS) Tanılı Bireylerin Öznel İyi Oluş Durumlarının İncelenmesi
I. Lisansüstü Hemşirelik Araştırmaları Sempozyumu, Samsun, Türkiye, 26 Kasım 2020
Multiple Skleroz (MS) Tanısı Almış Bireylerin, MS’e İlişkin Algılarının Belirlenmesi: Bir Metafor Analizi Çalışması
1. Lisansüstü Hemşirelik Araştırmaları Sempozyumu, Samsun, Türkiye, 26 - 29 Kasım 2020
Davetli Konuşmacı
56.Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım 2020
Bilimsel Sekreterya
11.Klinik Nöroimmunoloji Sempozyumu, Türkiye, 19 Kasım 2020
MOG IgG Related Disorders: Different Clinical Presentations
6th Congress of the European Academy of Neurology, 23 Mayıs 2020
Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020
Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020
Identification of Therapeutic Lag in Multiple Sclerosis
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Şubat - 01 Mart 2020
of Therapeutic Lag in Relapsing Multiple Sclerosis
Conference of MS-Research-Australia, 31 Ekim - 01 Kasım 2019
Impact Of Eculizumab On Quality Of Life In AQP4NMOSD: Findings From The PREVENT Study
Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020
Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study
Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020
Caregiver Burden in MS
Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020
Long-term Safety And Effectiveness Of Eculizumab In Neuromyelitis Optica Spectrum Disorder
Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020, ss.107
Does Obesity Affect Clinical Course in Patients with Multiple Sclerosis?
2. Uluslararası Sağlıklı Beslenme Kongresi, Ankara, Türkiye, 10 - 12 Ekim 2019
MULTİPL SKLEROZ HASTALARINDA OBEZİTE KLİNİK SEYRİ ETKİLER Mİ?
2. Uluslararası Sağlıklı Beslenme Kongresi, Ankara, Türkiye, 10 - 12 Ekim 2019
BİR ULUSAL ÇALIŞMANIN YÖNTEMİ (ENVIROPIMS): YENİ TANI ALMIŞ ERİŞKİN, ERGEN VE ÇOCUK MULTİPLE SKLEROZ(MS) OLGULARINDA OBEZİTE, SAĞLIKLI BESLENME VE FİZİKSEL AKTİVİTE DURUMUNUN ARAŞTIRILMASI
55. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 15 - 21 Kasım 2019
MULTİPL SKLEROZ HASTALARINDA FİNGOLİMOD TEDAVİSİNİN ETKİLİLİĞİ : TÜRKİYE GERÇEK YAŞAM VERİLERİ (REFINE)
55. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 15 - 21 Kasım 2019
Multipl Skleroz Hastalarında Fingolimod Tedavisinin Etkililiği : Türkiye Gerçek Yaşam Verileri
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2019
Olgu örnekleri ile MS, NMO, ADEM ve demyelinizan hastalıklar spektrumunda BOS incelemesi
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019
Gebelik ve İmmün Kökenli Nörolojik Hastalıklar:Planlama-İzlem ve Tedavi
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019
MULTİPL SKLEROZ HASTALARINDA FİNGOLİMODTEDAVİSİNİN ETKİLİLİĞİ : TÜRKİYE GERÇEK YAŞAMVERİLERİ (REFINE)
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2019, ss.276
SS-77 BİR ULUSAL ÇALIŞMANIN YÖNTEMİ (ENVIROPIMS):YENİ TANI ALMIŞ ERİŞKİN, ERGEN VE ÇOCUK MULTİPLESKLEROZ(MS) OLGULARINDA OBEZİTE, SAĞLIKLIBESLENME VE FİZİKSEL AKTİVİTE DURUMUNUNARAŞTIRILMASI
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019, ss.45
Efficacy Of Rituximab in Neuromyelitis Optica Spectrum Disorder: A Retrospective-Multicenter Study
İstanbul MS Days VI, İstanbul, Türkiye, 31 Ekim - 02 Kasım 2019
Panel Tartışması
MS Days VI, İstanbul, Türkiye, 31 Ekim - 02 Kasım 2019
The relationship between clinical and demographic characteristics and suicidal ideation in patients with multiple sclerosis
XXIV WORLD CONGRESS OF NEUROLOGY - WCN 2019, Dubai, Birleşik Arap Emirlikleri, 27 - 31 Ekim 2019
Does obesıty affect clınıcal course in patients with multiple sclerosis
2. ULUSLARARASI sAĞLIKLI BESLENME KONGRESİ, Ankara, Türkiye, 10 - 12 Ekim 2019, ss.391-402
OTURUM BAŞKANI
4. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Kütahya, Türkiye, 4 - 05 Ekim 2019
SEMPOZYUM DÜZENLEME KURULU
Multipl Skleroz Hasta Bakım Sempozyumu, Mardin, Türkiye, 20 - 22 Eylül 2019
OTURUM BAŞKANI-25 Adım Yürüme Testi, 9 Delikli Test, PASAT Testi Eğitimi ve Sertifikasyon
Multipl Skleroz Hasta Bakım Sempozyumu, Mardin, Türkiye, 20 - 22 Eylül 2019
EDSS, MSFC, 25 Adım Yürüme Testi Nasıl Yapılır? Hasta Takibinde ve İlaç Raporlarındaki Yeri Nedir?
Multipl Skleroz Hasta Bakım Sempozyumu, Mardin, Türkiye, 20 - 22 Eylül 2019
Long-term safety and effectiveness of eculizumab in neuromyelitis optica spectrum disorder
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Therapeutic lag in relapsing multiple sclerosis
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
MS cohorts and treatment utilization in academic centres in the Middle East
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Multiple Sclerosis Severity Score (MSSS) helps predict relapses and recovery from disability in patients treated for multiple sclerosis in the MSBase model
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Aggressive form of multiple sclerosis can be predicted early after disease onset
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Modifiers of the effectiveness of MS immunotherapies
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Determinants of therapeutic lag in relapsing multiple sclerosis
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Real-world experience with Ocrelizumab in the MSBase Registry
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019
EVALUATİON OF RELATIONSHIP BETWEEN VISCERAL ADIPOSITY INDEX (VAI) AND LIPIDS IN MULTIPLE SCLEROSIS (MS) PATIENTS
4 1ST ESPEN CONGRESS, Krakow, Polonya, 31 Ağustos - 03 Eylül 2019, cilt.38, ss.234
EVALUATION OF RELATIONSHIP BETWEEN VISCERAL ADIPOSITY INDEX (VAI) AND BLOOD LIPIDS IN MULTIPLE SCLEROSIS (MS) PATIENTS
41st ESPEN Congress, Krakow, Polonya, 31 Ağustos - 03 Eylül 2019, cilt.38, ss.234
Multipl Skleroz Epidemiyolojisi, Genetik ve Çevresel Risk Faktörleri
1. Multipl Skleroz ve Otoimmun Hastalıklarda Çocukluktan Erişkinliğe Geçiş Sempozyumu, Kütahya, Türkiye, 14 - 16 Haziran 2019
OTURUM BAŞKANI - Erken MS Rehabilitasyonu: Gözden Kaçan Bir Fırsat Penceresi mi ?
MS’xxDE SAĞLIKLI YAŞAM SEMPOZYUMU, İzmir, Türkiye, 25 - 26 Mayıs 2019
Clinical determinants and therapeutic modifiers of relapse and disability outcomes in neuromyelitis optica spectrum disorder
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019
Nöroimmunolojik hastalıklarda laboratuvardan kliniğe
III. Klinik Nöroimmünoloji Akademisi, Trabzon, Türkiye, 20 - 21 Nisan 2019
Tedaviyi Sonlandırmak Mümkün mü?
8. TEMEL İMMUNOLOJİ VE NÖROİMMUNOLOJİ OKULU 2019, Muğla, Türkiye, 4 - 07 Nisan 2019
OTURUM BAŞKANI :Nöroimmunolojik Testleri Tanımak ve Anlamak – Laboratuvardan Kliniğe
8. TEMEL İMMUNOLOJİ VE NÖROİMMUNOLOJİ OKULU 2019, Muğla, Türkiye, 4 - 07 Nisan 2019
ANTİ MYELİNE OLİGODENTROCYTE GLİCOPROTEİN (ANTİ-MOG) POZİTİF TESPİT EDİLEN 3 OLGU: 3 FARKLI KLİNİK PREZENTASYON
9.NÖROİMMUNOLOJİ OKULU, MUĞLA DALAMAN, Türkiye, 4 - 07 Nisan 2019
MOG’la İlişikili Demiyelinizan Hastalıklar
14. Uludağ Nöroloji Günleri, Bursa, Türkiye, 10 - 13 Mart 2019
The relationship between CSF oligoclonal band positivityand IgG index and visual evoked potential measurementsin patients with multiple sclerosis
17. ulusal sinir bilim kongresi, Türkiye, 4 - 07 Nisan 2019, cilt.13, ss.26
DÜZENLEME VE BİLİMSEL KURUL
International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019
OTURUM BAŞKANI - MULTİPL SKLEROZ’DA LABROTUVAR
International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019
Multipl Skleroz’da BOS
International Turkic World Congress of Multiple Sclerosis, İstanbul, Türkiye, 14 - 17 Şubat 2019
NÖROLOJİDE MESLEK HASTALIKLARI VE ÇEVRE SAĞLIĞI ÇALIŞTAYI- Çevresel Faktörler ve Multipl Skleroz
54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018
Nöromiyelitis Optika Spektrumunda Anti Miyelin Oligodendrosit Glikoprotein (Mog) Pozitifliği
54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018
MS, NMO, ADEM ve Demiyelinizan Hastalıklar Spektrumunda BOS İncelemesi
54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018
NÖROMİYELİTİS OPTİKA SPEKTRUMUNDA ANTİ MYELİN OLİGODENDROSİT GLİKOPROTEİN(MOG) POZİTİFLİĞİ
54. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, ss.236
MS’TE SEMPTOMATİK TEDAVİLER
3. MULTİPL SKLEROZDA KOGNİSYON SEMPOZYUMU, İzmir, Türkiye, 10 - 11 Kasım 2018
MULTİPL SKLEROZDA FİNGOLİMOD TEDAVİSİ SONRASI GELİŞEN GEBELİĞİN HASTALIK SEYRİNE OLAN ETKİSİ
MS DAYS V, KYRENIA, 2 - 04 Kasım 2018, ss.15
UNDERSTANDİNG MS AND İTS MANAGEMENT İN TURKEY İN 2018
MS DAYS V, 2 - 04 Kasım 2018
Nöroimmünoloji Laboratuarı
13. ÇUKUROVA NÖROLOJİ GÜNLERİ, Gaziantep, Türkiye, 19 - 21 Ekim 2018
Olgularla İnflamatuar SSS ve PSS Hastalıklarında Tanı ve Tedavi Gecesi
13. ÇUKUROVA NÖROLOJİ GÜNLERİ, Gaziantep, Türkiye, 19 - 21 Ekim 2018
RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the ’xxRELOMS-T’xx
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.100
Familial multiple sclerosis: comparing demographic and clinical characteristics with sporadic form
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.31
Early clinical predictors of severe MS
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.164
Determinants of MS re-activation after discontinuing therapies
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.122
Disability outcomes in patients with early cerebellar symptoms in multiple sclerosis
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.93
Determinants of disability accumulation in secondary-progressive multiple sclerosis
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.30
Clinical and therapeutic predictors of relapse and disability outcomes in neuromyelitis optica spectrum disorder
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.164
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remetting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.31
SEMPOZYUM BİLİMSEL KURULU
MS MASTER 2018, Nevşehir, Türkiye, 28 - 30 Eylül 2018
Demiyelinizan Hastalıklarda Ayırıcı Tanı
MS MASTER 2018, Nevşehir, Türkiye, 28 - 30 Eylül 2018
Yeni Ufuklar – Bunun “medium”u var mı? Engelliğin Ölçümünde Giyilebilir TeknolojilerOturum Başkanları: Dr. Murat Terzi
2. Multipl Sklerozda Fiziksel Engelliliğin Ölçümü Sempozyumu, İzmir, Türkiye, 19 - 20 Mayıs 2018
X. Oturum: MS’de Nörorehabilitasyon Çalışma Gruplarının Oluşturulması- Oturum Başkanı
3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018
KOORDİNATÖR
3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018
V.Oturum: Nörorehabilitasyonda Müzik Terapi- Oturum Başkanı
3. Multipl Sklerozda Fizyoterapi ve Nörorehabilitasyon Sempozyumu, Samsun, Türkiye, 11 - 13 Mayıs 2018
Let’s raise the awareness of MS specialistsconcerning the frequency and impact of RLS in MS and consequently the life quality ofpatients with MS: Striking results of the ‘RELOMS-T’ Study.
American Academy ofNeurology, 21 Mart - 27 Nisan 2018
KONUŞMACI.
10. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 1 - 05 Nisan 2018
Multipl Sklerozda Veri Girişinde Karşılaşılan Sorunlar
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018
Oturum Başkanı
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018
Örnek Veri Tabanlarına Hasta Girişi Pratiği
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018
DÜZENLEME KURULU
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018
Oturum Başkanı: Multipl Skleroz’da Klinik Hemşireliği Desteğinin Geliştirilmesi ve Ortak Projeler –Yurtdışı Proje Örnekleri
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Türkiye, 24 - 25 Mart 2018
Vitamin D Receptor Gene Polymorphism in Patients with Multiple Sclerozis
Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), 24 - 26 Şubat 2018, cilt.24, ss.117-118
Variables that affect life satisfaction of multiple sclerosis patients acomparative study
PACTRİMS 2017, Vietnam, 22 - 25 Kasım 2017, ss.33
MULTİPL SKLEROZDA TERİFLUNAMİD TEDAVİSİ GERÇEK YAŞAM VERİSİ
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
EPİLEPTİK NÖBET İLE PREZENTE OLAN NÖROSARKOİDOZ OLGUSU
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
MULTIPL SKLEROZ HASTALARINDA İNTERFERON BETA 1A SUBKUTAN HAFTADA 3 TEDAVİSİ GERÇEK YAŞAM VERİSİ
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
MULTİPL SKLEROZ’DA FİNGOLİMOD TEDAVİSİNİN LABORATUAR PARAMETRELERİ ÜZERİNE ETKİSİ
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
AKTİF RELAPSİNG REMİTTİNG MULTİPL SKLEROZ HASTALARINDA BİRİNCİ BASAMAKTA FİNGOLİMOD KULLANIMI
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
MULTİPL SKLEROZ HASTALARINDA DOĞUM SIRASININ KLİNİKLE OLAN İLİŞKİSİ
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
Variables that Affect Life Satisfaction of Multiple Sclerosis Patients a Comparative Study
PACTRIMS 2017, Vietnam, 23 - 25 Kasım 2017, ss.33
MULTIPL SKLEROZ’DA MORTALİTE
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
MULTİPL SKLEROZ ARTIK HBS SEKONDER NEDENLERİ ARASINDA YERİNİ ALMALI!: BU ALANDA ŞİMDİYE KADAR YAPILMIŞ EN GENİŞ ÇAPLI ÇALIŞMANIN [MULTİPL SKLEROZUN HUZURSUZ BACAKLARI-TÜRKİYE (RELOMS-T)] ÇARPICI SONUÇLARI
53. ULUSAL NÖROLOJİ KONGRE, Türkiye, 24 Kasım 2017 - 30 Ocak 2018, ss.54
MS Tedavisinde Teriflunomide ve Fingolimod’un Karşılaştırmalı Etkinlik Verileri
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017, ss.54
Orta ve Doğu Karadeniz Bölgesinde Pediyatrik ve Yetişkin Multipl Skleroz Hastalarının Demografik ve Klinik Özellikleri
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017, ss.87
MS TEDAVİSİNDE TERİFLUNOMİDE VE FİNGOLUMOD’UN KARŞILAŞTIRMALI ETKİNLİK VERİLERİ
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017, ss.54-55
Ms Tedavisinde Kullanılan İlaçların Kesilme Oranları ve Nedenleri
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
MULTİPL SKLEROZ HASTALARINDA GLATİRAMER ASETAT TEDAVİSİNİN GÜNLÜK VE HAFTADA 3 KULLANIMI İLAÇ MEMNUNİYETİ
53. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.230-231
Klinik İzole Sendromda Cladribine Deneyimi
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017
Multipl Skleroz Artık HBS Sekonder Nedenleri Arasında Yerini Almalı! : Bu Alanda Şimdiye Kadar Yapılmış En Geniş Çaplı Çalışmanın(Multipl Sklerozun Huzursuz Bacakları- Türkiye (RELOMS-T)) Çarpıcı Sonuçları
53. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 24 - 30 Kasım 2017, ss.54
De Novo Trigeminal Neuralgia Induced by Dalfampridine (4-aminopyridine): 3 cases
Pan-Asian Committee for treatment snd research in multiple sclerosis, 23 - 25 Kasım 2017
VARIABLES THAT AFFECT LİFE SATISFACTİON OF MULTİPLE SCLEROSİS PATİENTS A COMPARATİVE STUDY
Pan-Asian Committee on Treatment and Research in Multiple Sclerosis (PACTRIMS)., 22 - 25 Kasım 2017
Risk of secondary progressive multiple sclerosis: a longitudinal study
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.109-112
Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)Location: Paris, FRANCEDate: OCT 25-28, 2017, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.71-73
A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: patients switching within firstline agents or to natalizumab or fingolimod in active RRMS
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)Location: Paris, FRANCEDate: OCT 25-28, 2017, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.395-397
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis
ECTRIMS 2017, 25 - 28 Ekim 2017
FREQUENCY OF COGNİTİVE İMPAİRMENT İN RELAPSİNG-REMETTİNG MULTİPLE SCLEROSİS PATİENTS İN TURKEY AND AFFECTİNG FACTORS
ECTRIMS 2017, 25 - 28 Ekim 2017
Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.361-363
Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.325-327
The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.992-994
Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017
Contribution of inflammation to disability accrual in primary progressive multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.399-401
The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis
ECTRIMS 2017, 25 - 28 Ekim 2017, ss.47
Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis
MULTIPLE SCLEROSIS JOURNAL, Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.130-132
Deep brain stimulation for Multiple Sclerosis related tremor: clinical reports
3RD CLINICAL NEUROSCIENCE COURSE, Samsun, Türkiye, 19 - 22 Ekim 2017
DRUG SATISFACTION İN MULTİPLE SCLEROSİS USİNG FİNGOLİMOD TREATMENT
WORLD CONGRESS OF NEUROLOGY 2017, 16 - 21 Eylül 2017
Pediatrik başlangıçlı multiple skleroz ile erişkin başlangıçlı multiple sklerozun klinik özelliklerinin karşılaştırılması
19. Ulusal Çocuk Nörolojisi Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017
Multipl Skleroz Hastalarında Yorgunluğun Yaşam Kalitesine Olan Etkisi
8. Nöroimmunoloji Okulu, Türkiye, 30 Mart - 02 Nisan 2017
FİNGOLİMOD TEDAVİSİ KULLANAN MULTİPL SKLEROZHASTALARINDA İLAÇ MEMNUNİYETİ
8. Nöroimmunoloji Okulu, Türkiye, 30 Mart - 02 Nisan 2017
MS İN 1 BASAMAK TEDAVİSİNDE ORAL SEÇENEK TERİFLUNOMİD VE TÜRKİYE GERÇEK YAŞAM VERİLERİ
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
EP 249 Osteo artiküler Tutulum ve Polinöropati ile Prezente Olan Amiloidoz Vakası
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
TÜRKİYE DE FİNGOLİMOD İLE İLGİLİ GERÇEK YAŞAM DENEYİMLERİNDE ETKİNLİK
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
MULTİPL SKLEROZDA PROGNOZDA BOS UN ÖNEMİ
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
Nöromiyelitis Optica ve Gebelik
52.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016
S 32 Dramaterapi nin Multipl Skleroz Hastalarının Yaşam Kalitesine Olan Etkisi
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
S 88 Multipl Skleroz Hastalarında Fingolimod Tedavisinin Türkiye Gerçek Yaşam Verisi
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
S 80 Multipl Sklerozda Fingolimod Tedavisinin Özürlülük ile İlişkisi
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016, ss.51
MS TE 1 BASAMAK ENJEKSİYON TEDAVİLERİNE HALA İHTİYAÇ VAR MI
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
BP 63 Nöromiyelitis Optika ve Gebelik
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
Nöromiyelitis Optika ve Gebelik
52. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016
İKİNCİ BASAMAK TEDAVİ KARARINDA DİKKAT EDİLECEK NOKTALAR NELERDİR
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
BP 59 Susac Sendromlu 19 Olgu
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
TEP 140 Nöromiyelitis Optika ve Gebelik
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
SUSAC SENDROMLU 19 OLGU
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016, ss.107
MULTIPL SKLEROZ HASTALARINDA FİNGOLİMOD TEDAVİSİNİN TÜRKİYE GERÇEK YAŞAM VERİSİ
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016, ss.56
multiple skleroz hastalığında fingolimod tedavisinin Türkiye gerçek yaşam verisi
52. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 25 Kasım - 01 Aralık 2016
Değiştirilemez gerçekte anlam bulmak
52. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2016, cilt.27, ss.173
OLGU EŞLİĞİNDE MS HASTASINA YAKLAŞIM
11. ÇUKUROVA NÖROLOJİ GÜNLERİ, Türkiye, 30 Eylül - 02 Ekim 2016
Individual response to disease modifying therapies a global observational cohort study
32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016
Outcomes of pregnancy in neuromyelitis optica patients:turkish multicenter study data
ECTRIMS 2016 - 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis., Londrina, Brezilya, 14 - 17 Eylül 2016
Efficacy and the safety profile of fingolimod treatment in multiple sclerosis patients: Real-life data from Turkey
32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis. ECTRİMS-2016, Londrina, Brezilya, 14 - 17 Eylül 2016
Comparative analysis of MS outcomes in natalizumab treated patients using a novel three way multinomial propensity score match
32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016
Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey
ECTRIMS 2016 - 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis., Londrina, Brezilya, 14 - 17 Eylül 2016
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016
Anti inflammatory disease modifying treatment does not attenuate disability progression in secondary progressive multiple sclerosis
32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016
Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a
ECTRIMS 2016, 13 - 16 Eylül 2016
MS TE YORGUNLUĞUN DEĞERLENDİRİLMESİ
IX. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 2 - 04 Haziran 2016
NÖRODEJENERASYON
IX. KLİNİK NÖROİMMUNOLOJİ SEMPOZYUMU, Türkiye, 2 - 04 Haziran 2016
OTURUM BASKANI
VI. TEMEL İMMÜNOLOJİ VE NÖROİMMÜNOLOJİ ÖĞRENCİ OKULU, Türkiye, 8 - 09 Nisan 2016
MULTI PLE SKLEROZ I LI S KI LI TREMOR VAKALARINDA DERI N BEYI N STI MU LASYONU
TND 30. BİLİMSEL KONGRESİ, Türkiye, 8 - 12 Nisan 2016
Demyelinating diseases of the central nervous system
2nd Neuroscience Stereology and Scientific Writing, 15 - 19 Mart 2016
EP 35 Deep brain stimulation for multiple sclerosis related tremor Clinical reports
1. INTERNATİANOL CONFERENCEON DEEP BRAİN STİMULATİON, 5 - 16 Mart 2016
MS TEDAVİSİNDE GEÇİŞLERİ NE ZAMAN YAPALIM
11. ULUDAĞ NÖROLOJİ GÜNLERİ, Türkiye, 10 - 13 Mart 2016
Ailevi multipl skleroz
51. ulusal nöroloji kongresi konuşma, Türkiye, 28 Kasım - 03 Aralık 2015
elektrokonvülzif tedavi uygulanan gebede anestezi yönetimi olgu sunumu
Türk Anesteziyoloji Derneği 49. Ulusal Kongresi, Antalya, Türkiye, 2 - 06 Aralık 2015
MULTiPL SKLEROZUN HUZURSUZ BACAKLARITÜRKiYE ÇOK MERKEZLi ULUSAL ÇAlıŞMANıNMETODOLOJİSİ
Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 03 Aralık 2015
Nörolojik Hastalıklarda plazmaferez ve IVIG
51. ulusal nöroloji kongresi konuşma, Türkiye, 28 Kasım - 03 Aralık 2015
fingolimod tedavisinin güvenilirliği
51. ULUSAL nöroloji kongresi, Türkiye, 28 Kasım - 02 Aralık 2015
RELAPSİNG REMTTİNG MULTİPL SKLEROZ HASTALARINDA FİNGOLİMOD TEDAVİSİNİN KLİNİK ÜZERİNE OLAN ETKİSİ
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
RELAPSİNG REMETTİNG MULTİPL SKLEROZ HASTALARINDA FİNGOLİMOD TEDAVİSİNİN GÜVENİLİRLİĞİ
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
SLEEVE GASTREKTOMİ SONRASI GELİŞEN WERNİCKE ENSEFALOPATİSİ
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
MULTİPL SKLEROZDA ENJEKSİYON ŞEKLİNDE KULLANILAN HASTALIK MODİFİYE EDİCİ İLAÇLAR NEDEN SONLANDIRILIR?
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
RRMS HASTALARINDA 12 AYLIK FİNGOLİMOD TEDAVİSİ SONUÇLARI: FİNE ÇALIŞMASI
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
MULTİPL SKLEROZUN HUZURSUZ BACAKLARI-TÜRKİYE: ÇOK MERKEZLİ ULUSAL ÇALIŞMANIN METODOLOJİSİ
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
MULTİPL SKLEROZ HASTALARINDA KLİNİK TECRÜBEYE GÖRE TANI, TEKİP VE TEDAVİ STRATEJİSİNDEKİ FARKLILIKLAR: MULTİPL SKLEROZ UZMANLARI VE GENEL NÖROLOGLAR İLE YAPILAN ANKET ÇALIŞMASI
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
NMO KLİNİĞİ İLE PREZENTE OLAN SJÖGREN SENDROMU
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
MULTİPL SKLEROZ HASTALARINDA SPİNAL KORD DEĞERLENDİRİLMESİ İÇİN T2 VE SHORT T1 İNVERSİON RECOVERY(STIR) MR BULGULARININ KARŞILAŞTIRILMASI
51. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 27 Kasım - 03 Aralık 2015
Efficacy and Treatment Persistence of First line Natalizumab vs Interferon beta or Glatiramer Acetate in relapsing MS
8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), 19 - 21 Kasım 2015
Nöromiyelitis optika klinik ve tedavisi
10. çukurova nöroloji günleri, Türkiye, 13 - 15 Kasım 2015
Short T1 inversion recovery and T2 weighted sequences comparing and correlation with clinical findings of multiple sclerosis spinal cord lesions
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), 7 - 10 Ekim 2015
Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 21 - 22 Ekim 2015
Comparison of efficacy and persistence of first line fingolimod vs interferon beta glatiramer in the presence of prior disease activity
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 21 - 23 Ekim 2015
10 year progression predictors after first treatment initiation in a relapsing remitting MS cohort
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 21 - 23 Ekim 2015
Effects of Short and Long Term of ElectromagneticField Exposure on the Human Hippocampus
BIOMED 2015, 21 - 24 Ekim 2015
A case of molluscum contagiosum developed during use of fingolimod
XXII World Congress of Neurology, 19 - 21 Kasım 2015
1st Congress of the European Academy of Neurology
MULTIPLE SCLEROSIS JOURNAL, 1 - 04 Mayıs 2015
Silika Destekli NiCoPt Nanokümelerinin Hazırlanması Tanımlanması ve Hidrazin Hidratın Dehidrojenlenme Tepkimesindeki Katalitik Performansının İncelenmesi
V. Ulusal Anorganik Kimya Kongresi, Türkiye, 22 - 25 Nisan 2015
Differences in Treatment Strategies in Multiple Sclerosis According to Experience A Survey of Multiple Sclerosis Experts and General Neurologists
67th Annual Meeting of American Academy of Neurology, Washington, Kiribati, 21 - 27 Nisan 2015
Differences in the Diagnosis and Follow up of Multiple Sclerosis Patients According to the Experience of Neurologists Results of a National Survey
67th Annual Meeting of American Academy of Neurology, Washington, Kiribati, 21 - 28 Nisan 2015
Otizm Spektrum Bozukluğu Olan Çocuğa Sahip Ailelerle Gerçekleştirilen Ailelerle El Ele Aile Eğitim Programına İlişkin Aile Görüşleri
24. Ulusal Özel Eğitim Kongresi, Trakya Üniversitesi, Edirme, Edirne, Türkiye, 9 - 11 Ekim 2014
Patients with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder: Turkish Multicenter Data
MULTIPLE SCLEROSIS JOURNAL, 6 - 08 Kasım 2014, cilt.21, ss.824-825
DEMİYELİNİZAN HASTALIĞINI TAKLİT EDEN SPİNAL MENENJİOM OLGUSU
50. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 21 - 27 Kasım 2014
RRMS HASTALARINDA FİNGOLİMOD TEDAVİSİ BAŞLANGICININ KARDİYAK GÜVENLİLİĞİ
50. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 21 - 27 Kasım 2014
Evaluation of common criteria of progression of disability in a large observational cohort
ECTRIMS 2014, 10 - 13 Eylül 2014
RESTLESS LEG SYNDROME AND MULTİPLE SCLEROSİS
ECTRIMS 2014, 10 - 13 Eylül 2014
NMOBase is a Web-based, global observational registry for an ‘orphan’ disorder: neuromyelitis optica
ECTRIMS 2014, 10 - 13 Eylül 2014
Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
ECTRIMS 2014, 10 - 13 Eylül 2014
Independent predictors of time to relapse after CIS in high-risk patients
ECTRIMS 2014, 10 - 13 Eylül 2014
Effects of long term of electromagnetic field exposure on the human hippocampus.
Stereology and Neuroscience Symposium, 23 Haziran 2014
Stereological and comparative evaluation of the carpal tunnel in patients with carpal tunnel syndrome using magnetic resonance images
3. International Scientific Writing&Stereology Workshop, Ondokuz Mayıs University, 08-12 Nisan 2014 Samsun, Turkey, 8 - 12 Nisan 2014, cilt.31
Nöromiyelitis Optika ve Nöromiyelitis Optika Spektrumu
8. Klinik Nöroimmünoloji Sempozyumu, Türkiye, 3 - 06 Nisan 2014
KLİNİSYEN GÖZÜYLE NMO’NUN EVRİMİ
8. Klinik Nöroimmünoloji Sempozyumu, Türkiye, 3 - 06 Nisan 2014
Multipl Skleroz Hastalığı Tanı Süreci Klinik ve Radyolojik Bulgular ile Yardımcı İncelemelerin Yeri.
49. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2013
Türkiye de 18 60 Yaş Arası Multipl Skleroz Olgularının Tahmini İnsidans Değeri ve Demografik Özellikleri
49. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2013
2000 YILINDAN SONRA KLİNİK BAŞLANGIÇ GÖSTEREN MULTİPL SKLEROZ DA KLİNİK VE DEMOGRAFİK ÖZELLİKLER FARKLI MI?
49. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 15 - 21 Kasım 2013
Does probe’s eye subthalamic nucleus length on T2W MRI correspond with microelectrode recording in patients with deep brain stimulation for advanced Parkinson’s disease ?
The XV WFNS World Congress of Neurological Surgery Meeting, SEUL, 8 - 13 Kasım 2013
THE BENEFİTS OF VİSUAL EVOKED POTENTİAL EXAMİNATİON İN THE DİAGNOSİS AND PROGNOSİS OF MULTİPL SCLEROSİS
WORLD CONGRESS OF NEUROLOGY 2013, 21 - 26 Eylül 2013
Derin beyin stimülasyonu uygulanan Parkinson hastalarında aksiyal T2W MR’da probe eye ile ölçülen subtalamik nukleus uzunluğu, mikrolektrod kayıtla uyumlu mu?
Türk Nöroşirürji Derneği 27. Bilimsel Kongresi, Antalya, Türkiye, 12 - 16 Nisan 2013
Multiple skleroz hastasında trigeminal-glossofaringeal nevralji birlikteliği
Türk Nöroşirürji Derneği 27. Bilimsel Kongresi, Antalya, Türkiye, 12 - 16 Nisan 2013
MULTİPL SKLEROZ HASTALARININ KLİNİK BAŞLANGIÇ SEMPTOMLARININ HASTALARIN KLİNİK VE DEMOGRAFİK ÖZELLİKLERİYLE OLAN İLİŞKİSİ
48. ULUSAL NÖROLOJİ KONGRESİ, Türkiye, 16 - 22 Kasım 2012
Targetin thalamic tremor cells in deep brain stimulation for multiple sclerosis induced complex tremor’
20. Congress of the European Society for Stereotactic and Functional Neurosurgery, 26 - 28 Eylül 2012
Türkiye’de Multipl Skleroz Hastalarında Serum JCV Antikor Prevelansının Belirlendiği Gözlemsel Çalışma
47. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2011
Evaluation of event related potentials in vitamin B12 deficient patients with functional cognitive deterioration
JOURNAL OF NEUROLOGY (ENS 2011), 01 Ocak 2011, cilt.258, ss.179
Methyl prednisolone responsive myeloradiculopathy associated with EBV infection
JOURNAL OF NEUROLOGY (ENS 2011), 01 Ocak 2011, cilt.258, ss.242-243
Isaacs syndrome clinical and electrophysiological response to Botulinum toxin type A
JOURNAL OF NEUROLOGY (ENS 2011), 01 Ocak 2011, cilt.258, ss.247
Evaluation of Anger Anger Expression Style and Mood Profiles inTension Type Headache
NEUROLOGY (AAN 2011), 01 Ocak 2011, cilt.76, ss.202
Do polymorphisms at the CD14 promotor gene and soluble CD14 levels effect biological response to IFN therapy in Multiple Sclerosis
10th International Congress of Neuroimmunology., SITGES, İspanya, 26 - 30 Ekim 2010
Do polymorphism at the CD14 promotor gene and soluble CD14 levels effect biological response to IFNbeta therapy in multiple sclerosis?
10th International Congress of Neuroimmunology, 26 - 30 Ekim 2010
Tumefactive multiple sclerosis lesions: demographic, clinical, radiological characteristics
26rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 10 - 12 Ekim 2010
Eye-of-tiger sign in multiple sclerosis: a case report
14th Congress of the European Federation of Neurological Societies, 26 - 28 Eylül 2010
Comparison of duloxetine and pregabalin treatments in neuropathic pain
EUROPEAN JOURNAL OF NEUROLOGY (EFNS 2010), 01 Ocak 2010, cilt.17, ss.262
Decompression surgery in trigeminal neuralgia caused by basilar artery dolicoectasia
EUROPEAN JOURNAL OF NEUROLOGY (EFNS 2010), 01 Ocak 2010, cilt.17, ss.264
Tedaviye Dirençli Epileptik Nöbetleri Olan Multiple Skleroz Olgusu
45. Ulusal Nöroloji Kongresi, Türkiye, 10 - 15 Kasım 2009
Is there a correlation between evoked potentials and clinical findings in Multiple Sclerosis?
19th World Congress of Neurology, 24 - 30 Ekim 2009, ss.216-217
CSF oligoclonal band as a marker for prognosis in Multiple Sclerosis
19th World Congress of Neurology, 24 - 30 Ekim 2009
Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
19th World Congress of Neurology, 24 - 30 Ekim 2009
Tedaviye Dirençli Epileptik Nöbetleri Olan Multipl Skleroz Olgusu
Tedaviye Dirençli Epileptik Nöbetleri Olan Multipl Skleroz Olgusu, Türkiye, 10 - 15 Ekim 2009
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009, ss.200
Any realtion between multiple sclerosis and bone metabolism?
25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009, ss.166
Evoked potentials in multiple sclerosis
25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009
Multiple sclerosis and vitamin B12 metabolism
25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 - 12 Eylül 2009
Factors associated with osteoporosis in patients with multiple sclerosis
5th World Congress of the International Society of Physical and Rehabilitation Medicine, 13 - 17 Haziran 2009
Parkinsonizmle Prezente Olan Karaciğer Sirozu İki Olgu Sunumu
44.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 11 - 15 Kasım 2008
Tumefactive demyelinating disease is immunologically different from multiple sclerosis
23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 11 - 14 Ekim 2007
Subakut Kombine Dejenerasyon Tanısı Alan 9 Olgunun Klinik ve Demografik Özellikleri
Subakut Kombine Dejenerasyon Tanısı Alan 9 Olgunun Klinik ve Demografik Özellikleri, Türkiye, 10 - 15 Ekim 2007
Periferal Nöropati ile Prezante Olan Anti Yo (+) Over Karsinomu: Olgu Sunumu
Periferal Nöropati ile Prezante Olan Anti Yo (+) Over Karsinomu: Olgu Sunumu, Türkiye, 10 - 15 Ekim 2007
Nörobehçette Klinik, Radyolojik ve Demografik Özellikler
Nörobehçette Klinik, Radyolojik ve Demografik Özellikler, Türkiye, 10 - 15 Ekim 2007
A comparative study of evoked potentials and EMG in Turkish patients with Multiple sclerosis and Neurobehçet’s syndrome
A comparative study of evoked potentials and EMG in Turkish patients with Multiple sclerosis and Neurobehçet’s syndrome, Türkiye, 2 - 07 Temmuz 2006
A comporative study of evoked potentials and EMG in Turkish patients with multiple sclerosis and neurobehçet’s syndrome
XIth international congress on neuromuscular diseases, 2 - 07 Temmuz 2006
Kluver-Bucy Sendromu
TMRD TÜRK MANYETİK REZONANS DERNEĞİ IX. Ulusal Manyetik Rezonans Derneği, Türkiye, 25 - 27 Mayıs 2006
Multipl skleroz plakları ile yaşlanmaya bağlı beyaz cevherde görülen hiperintens odakların ayrımında difüzyon ağırlıklı görüntülemenin yeri
26 . Ulusal Radyoloji Kongresi, Türkiye, 26 - 30 Ekim 2005
CSF total tau Protein Level and it Relation with Diffusion MRI in Multiple Sclerosis Patients
21rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 28 Eylül - 01 Ekim 2005
Esansiyel Tremorda Nöropsikolojik Profil ile Bölgesel Kan Akımı İlişkisi
38. Ulusal Nöroloji Kongresi, Türkiye, 19 - 23 Ekim 2002
Kitap & Kitap Bölümleri
Her Yönüyle Kenevir
Ondokuz Mayıs Üniversitesi, Samsun, 2023
Multipl Skleroz’da Nörorehabilitasyon
Hipokrat, 2023
MULTİPL SKLEROZ VE BESLENME
MULTİPL SKLEROZ, YEŞİM BECKMAN CİHAT UZUNKÖPRÜ, Editör, EMA TIP KİTAPEVİ, İstanbul, ss.537-549, 2021
Multipl Skleroz
Sakarya Matbaacılık, 2020
Soru ve Yanıtlarla Multipl Skleroz
No-bel Matbaacılık San.Tic.Ltd. Şti., 2018
Soru ve Yanıtlarla Multipl Skleroz
Ömür Matbaacılık, 2016